Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 2,331 | 2,686 | 3,271 | 5,195 | 2,194 |
| Cost of Goods | 1,727 | 1,851 | 2,148 | 1,037 | 836 |
| Gross Profit | 604 | 835 | 1,124 | 4,158 | 1,358 |
| Operating Expenses | 3,053 | 2,890 | 2,509 | 3,629 | 4,907 |
| Operating Income | -1,722 | -1,205 | -1,238 | 566 | -2,713 |
| Interest Expense | 56 | 57 | 69 | 73 | 68 |
| Other Income | 1,575 | 5,500 | 2,403 | 7,482 | -9,452 |
| Pre-tax Income | -203 | 4,238 | 1,097 | 7,976 | -12,233 |
| Income Tax | -1,870 | N/A | 3 | -523 | N/A |
| Net Income Continuous | 1,667 | 4,238 | 1,094 | 8,499 | -12,233 |
| Net Income | $1,667 | $4,238 | $1,094 | $8,499 | $-12,233 |
| EPS Basic Total Ops | 0.00 | 0.03 | 0.00 | 0.03 | -0.05 |
| EPS Basic Continuous Ops | 0.00 | 0.01 | 0.00 | 0.01 | -0.02 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | 0.05 | -0.05 |
| EPS Diluted Continuous Ops | 0.00 | 0.01 | 0.00 | 0.01 | -0.02 |
| EBITDA(a) | $-1,563 | $-1,035 | $-1,062 | $740 | $-2,546 |